These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7563510)
1. Assessment of a universal, school-based hepatitis B vaccination program. Dobson S; Scheifele D; Bell A JAMA; 1995 Oct; 274(15):1209-13. PubMed ID: 7563510 [TBL] [Abstract][Full Text] [Related]
2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates. Gunn TR; Bosley A; Woodfield DG N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527 [TBL] [Abstract][Full Text] [Related]
3. A hepatitis B vaccination program targeting adolescents. Cassidy WM; Mahoney FJ J Adolesc Health; 1995 Oct; 17(4):244-7. PubMed ID: 8580125 [TBL] [Abstract][Full Text] [Related]
4. Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital. Catania G; Di Ciommo V; Concato C Recenti Prog Med; 1996 Jun; 87(6):271-4. PubMed ID: 8766952 [TBL] [Abstract][Full Text] [Related]
5. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine]. Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination in a school age population: a feasibility study. Zuckerman J; Langer B J Med Virol; 2005 May; 76(1):47-54. PubMed ID: 15778966 [TBL] [Abstract][Full Text] [Related]
7. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A; Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616 [TBL] [Abstract][Full Text] [Related]
8. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients. Tung J; Carlisle E; Smieja M; Kim PT; Lee CH Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640 [TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years. Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811 [TBL] [Abstract][Full Text] [Related]
10. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults. Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812 [TBL] [Abstract][Full Text] [Related]
12. [Preventive hepatitis B vaccination of hospital staff]. Jepsen LS; Thomsen AC Ugeskr Laeger; 1992 Aug; 154(36):2421-3. PubMed ID: 1413161 [TBL] [Abstract][Full Text] [Related]
13. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States. Spradling PR; Williams RE; Xing J; Soyemi K; Towers J Infect Control Hosp Epidemiol; 2012 Jul; 33(7):732-6. PubMed ID: 22669236 [TBL] [Abstract][Full Text] [Related]
14. [The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population]. Fu QP; He H; Li L; Chen HP; Zeng YX; Liu QL; Fang G; Dong CM; Guo SH; Li HG; Wang HY; He CS; Zhou SZ; Li L; Gu SN; Zhang ZF; Dai M Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Oct; 43(10):903-6. PubMed ID: 20137473 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. Schiff GM; Sherwood JR; Zeldis JB; Krause DS J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study. Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542 [TBL] [Abstract][Full Text] [Related]
17. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation. Wong J; Payne M; Hollenberg S J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children. Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363 [TBL] [Abstract][Full Text] [Related]
19. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants]. Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565 [TBL] [Abstract][Full Text] [Related]
20. Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students. Patrick DM; Bigham M; Ng H; White R; Tweed A; Skowronski DM Pediatr Infect Dis J; 2003 Oct; 22(10):874-7. PubMed ID: 14551487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]